BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34942479)

  • 1. Generation of an induced pluripotent stem cell line (SYSUi005-A) from a patient with hypertrophic cardiomyopathy.
    Zhang C; Shi J; Zhang Z; Zhao Q; Xie M; Chen Y; Xiang Q
    Stem Cell Res; 2022 Jan; 58():102626. PubMed ID: 34942479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of human induced pluripotent stem cell lines derived from four patients with a pathogenic ALPK3 variant associated with adult-onset hypertrophic cardiomyopathy (HCM).
    Cheawsamoot C; Ramchandani R; Ameen M; Arthur Ataam J; Khongphatthanayothin A; Shotelersuk V; Karakikes I
    Stem Cell Res; 2023 Dec; 73():103233. PubMed ID: 37944352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An induced pluripotent stem cell line (YCMi006-A) generated from a patient with hypertrophic cardiomyopathy who carries the ACTA1 mutation p.Ile343Met.
    Kim H; Kim HJ; Oh J; Lee ST; Won D; Choi HK; Choi JR; Kim S; Kim HP; Kim SJ; Park SW; Kang SM; Lee SH
    Stem Cell Res; 2022 Aug; 63():102874. PubMed ID: 35917599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of an induced pluripotent stem cell line, ICGi029-A, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.N515del mutation in MYBPC3.
    Dementyeva EV; Pavlova SV; Chernyavsky AM; Zakian SM
    Stem Cell Res; 2021 May; 53():102344. PubMed ID: 33892289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of induced pluripotent stem cells (iPSCs) from a hypertrophic cardiomyopathy patient with the pathogenic variant p.Val698Ala in beta-myosin heavy chain (MYH7) gene.
    Ross SB; Fraser ST; Nowak N; Semsarian C
    Stem Cell Res; 2017 Apr; 20():88-90. PubMed ID: 28395747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of induced pluripotent stem cells from a patient with hypertrophic cardiomyopathy who carries the pathogenic myosin heavy chain 7 mutation p.Arg403Gln.
    Holliday M; Ross SB; Lim S; Mangala M; Hill A; Szappanos HC; Hool L; Semsarian C
    Stem Cell Res; 2018 Dec; 33():269-273. PubMed ID: 30508693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of an induced pluripotent stem cell line (ZJULLi003-A) from a hypertrophic cardiomyopathy patient carrying MYH7/c.4384G > A mutation.
    Zhou J; Sun Y; Wang H; Wang H; Guo F; Chen X; Gong T; Jiang C; Liang P
    Stem Cell Res; 2022 Oct; 64():102883. PubMed ID: 35944310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a hiPSC line ZZUNEUi007-A from a patient with hypertrophic cardiomyopathy caused by mutation in MYH7.
    Li X; Liu Y; Liu F; Wang X; Liu M; Du W; Zhao J; Wang M; Hu L; Wang C; Fu W; Dong J; Zhao X
    Stem Cell Res; 2020 Mar; 43():101699. PubMed ID: 31931472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of an induced pluripotent stem cell line (ZJULLi004-A) from a hypertrophic cardiomyopathy patient carrying MYBPC3/c.3764C>A mutation.
    Sun Y; Zhou J; Wang H; Wang H; Chen X; Gong T; Liang P; Jiang C
    Stem Cell Res; 2022 Oct; 64():102898. PubMed ID: 36041398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of induced pluripotent stem cell lines from two unrelated individuals with familial hypertrophic cardiomyopathy carrying the MYBPC3 missense c.1484G>A mutation.
    Ribeiro M; Martins S; Carvalho T; Furtado M; Sampaio Cabral J; Brito D; Carmo-Fonseca M; da Rocha ST
    Stem Cell Res; 2024 Feb; 74():103282. PubMed ID: 38104429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of an induced pluripotent stem cell line from a hypertrophic cardiomyopathy patient with a pathogenic myosin binding protein C (MYBPC3) p.Arg502Trp mutation.
    Holliday M; Ross SB; Lim S; Semsarian C
    Stem Cell Res; 2018 Dec; 33():56-59. PubMed ID: 30316040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral blood derived induced pluripotent stem cells (iPSCs) from a female with familial hypertrophic cardiomyopathy.
    Ross SB; Fraser ST; Bagnall RD; Semsarian C
    Stem Cell Res; 2017 Apr; 20():76-79. PubMed ID: 28395744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A heterozygous MYH7 (c. 2156G > A) mutant human induced pluripotent stem cell line (ZZUNEUi020-A) generated from a patient with hypertrophic cardiomyopathy.
    Li X; Fu W; Guo G; Liu M; Du W; Zhao J; Liu Y; Wang L; Dong J; Zhao X
    Stem Cell Res; 2021 Mar; 51():102158. PubMed ID: 33453578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A heterozygous MYBPC3 (c. 772+1G > A) mutant human induced pluripotent stem cell line (ZZUNEUi025-A) generated from a male patient with hypertrophic cardiomyopathy.
    Zhao X; Cao J; Li X; Liu M; Liu Y; Dong J; Zhao X
    Stem Cell Res; 2022 Apr; 60():102722. PubMed ID: 35257994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of an induced pluripotent stem cell line, ICGi028-A, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.E510Q mutation in HADHA.
    Dementyeva EV; Vyatkin YV; Chernyavsky AM; Zakian SM
    Stem Cell Res; 2021 May; 53():102348. PubMed ID: 33887580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of an iPSC line (ZZUNEUi021-A) from a hypertrophic cardiomyopathy patient with TNNT2 mutation.
    Dong Y; Li X; Fu W; Tian X; Guo G; Peng Y; Zhai Y; Zhao J; Ding Z; Zhao X; Dong J
    Stem Cell Res; 2022 Jan; 58():102622. PubMed ID: 34929444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a healthy heavy smoker patient-derived induced pluripotent stem cell line UHOMi007-A from peripheral blood mononuclear cells.
    Ahmed E; Fieldès M; Bourguignon C; Mianné J; Petit A; Amel N; Foisset F; Bourdais C; Vachier I; Assou S; De Vos J; Bourdin A
    Stem Cell Res; 2024 Jun; 77():103437. PubMed ID: 38723411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of induced pluripotent stem cell line (XWHNi002-A) from a female with APP gene mutation.
    Sun W; Wang P; Gong J; Chen Y; Yang Y; Luan H; Li S; Li R; Wei C
    Stem Cell Res; 2023 Sep; 71():103149. PubMed ID: 37356183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of two clonal iPSC lines, ICGi019-A and ICGi019-B, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.M659I mutation in MYH7.
    Dementyeva EV; Kovalenko VR; Zhiven MK; Ustyantseva EI; Kretov EI; Vyatkin YV; Zakian SM
    Stem Cell Res; 2020 Jul; 46():101840. PubMed ID: 32422568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a hiPSC line ZZUNEUi017-A from a patient with dilated cardiomyopathy caused by mutation in TTN.
    Huang S; Fu W; Guo G; Tiana X; Zhao X; Dong J; Li X; Yang H
    Stem Cell Res; 2021 Apr; 52():102248. PubMed ID: 33610015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.